Your info will never be shared with a third-party
Allegro Press Releases
Allegro Ophthalmics Completes Enrollment in DEL MAR Phase 2b, Stage 2 Clinical Trial of Luminate® for the Treatment of Diabetic Macular Edema
December 15, 2016
William J. Link, PhD, Joins Allegro Ophthalmics’ Board of Directors
November 21, 2016
Allegro Ophthalmics Announces Positive Topline Results from DEL MAR Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema
October 13, 2016
Allegro Ophthalmics Announces Last Patient Enrolled in PACIFIC Phase 2b Clinical Trial of Luminate® for Non-Proliferative Diabetic Retinopathy
October 03, 2016
Allegro Ophthalmics Announces Two Executive Promotions
March 15, 2016
Vision & Mission
Bringing Our Vision to Life with Luminate®
Diabetes is increasing in the general population,1 and Allegro Ophthalmics foresaw the need to create a treatment to help DME patients. That’s where Luminate® comes in…
